Daily FNArena News - Australia

Implant volumes in Cochlear’s major markets appear to be on the mend, which is supportive of revenue, but concerns are emerging regarding another bout of elective surgery restrictions.

South32 has reinstated its buyback program, having built up cash reserves after a solid performance in the September quarter, while kicking off 2021 unencumbered by South Africa Energy Coal is considered critical to the outlook.

Delays stemming from the pandemic amid ebbing demand conditions confront Rio Tinto, while there is also work to do to improve perceptions about its cultural sensitivity.

As investors increasingly focus on technology companies, it is timely to review the investment thesis for Audinate

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Investor focus is firmly on life sciences companies in 2020. FNArena highlights six ASX-listed entities that have been viewed positively by analysts recently

Everything needs to fall into place for Bank of Queensland to achieve an acceleration in credit growth in FY21, despite a strong balance sheet.

HUB24 continues to sustain significant momentum, enabling the wealth management business to withstand the pressures on the industry.

Bravura Solutions continues to broaden its services, having acquired the UK’s Delta Financial Systems. However, given the pandemic is far from over, it is unclear how smooth the going will be.

Bapcor is racing ahead, delivering strong vehicle parts sales, and envisaging plenty of opportunity for industry consolidation.